Purpose: The present study examined the effect of low-dose thumb exertion on lymphocyte subpopulation trafficking. The potential role of blood lactate in mediating lymphocyte redistribution was also investigated. Methods: 27 male participants (18 weightlifting-trained; 9 untrained) were separated into 3 groups of 9 (Weightlifting and Untrained Experimental: WLEXP, UTEXP; Weightlifting Placebo: WLPLA). WLEXP and UTEXP performed 4x60 second isometric thumb intervals separated by 60 second rest intervals in a single-blinded placebo-controlled study. Participants were assessed over a 60 minute post-intervention recovery period for pain, blood lactate and lymphocyte subpopulation counts. Results: WLPLA did not change for any measured variable (p>0.05). The two experimental groups increased significantly (p<0.01) in thumb pain post-intervention (WLEXP:4.92/10; UTEXP:2.92/10) however only WLEXP remained elevated across all time-points. Blood lactate increased for both experimental groups post-intervention (p<0.01) whilst peak concentrations (UTEXP: 2.2mmol/L; WLEXP: 2.4mmol/L) and temporal profiles were not different between groups (p>0.05). No differences in cell count were seen for CD56+/CD16+ lymphocytes across time for any group (p>0.05). UTEXP showed an early significant increase (20 min post-intervention) in CD4+CD3+ (20.78%, p<0.01), CD8+CD3+ (15.25%, p<0.01) and CD19+ (18.11%, p=0.013) cell count before returning to levels not different from baseline by the final time-point (p>0.05). Conversely, WLEXP group showed no early increase followed by a delayed increase in cell count evident at the final time-point; CD4+CD3+ (19.06%, p<0.01), CD8+CD3+ (11.46%, p=0.033) and CD19+ (28.87%, p<0.01). Blood lactate was not correlated with lymphocyte counts. Conclusions: Physical aptitude and not cellular energy demand influences the lymphocyte response to resistance-exercise.
. Each participant attended the testing laboratory (temperature monitored at 23 °C) on one single occasion only. The session began with a pre-screening where a Doctor of Physical Therapy confirmed that subjects were apparently healthy. Subjects were excluded based on: past or present history of upper limb/hand musculoskeletal pathology, cardiovascular, metabolic, or respiratory illness; contraindications to resistanceexercise (Pollock et al., 2000) . Subjects were then familiarised with the B & L Pinch dynamometer (B & L Engineering, CA, USA) and the MVC (maximum voluntary contraction) assessment using the familiarisation procedure described previously (Szlezak et al., 2015) . Briefly, participants were seated in a standardised testing position as recommended by the American Society of Hand Therapists (Fess & Moran, 1981) . Only the dominant hand was utilised for the purpose of achieving maximal efforts. Participants were instructed to perform 5 sub-maximal pinch efforts separated by 30 seconds rest before immediately completing a maximal-effort practice session identical to the testing session (see 2.3.1 MVC Assessment). This familiarisation procedure also ensured that any pre-fatiguing effect associated with this procedure was consistent across all research participants. Participants were also shown a copy of the Pain Visual Analogue Scale (VAS) and were instructed on how to complete it. Following familiarization, an Intravenous (IV) catheter was inserted into the median cubital vein of the participant's dominant hand and was left insitu for serial blood sampling. This sampling method promoted precise timing of blood collection, and avoided repeat needle-trauma which could affect results. Blood for lymphocyte assessment was collected directly into an EDTA Vacutainer (Becton Dickinson, NJ, USA) and analysed within 60 minutes. Blood for lactate analysis was drawn with a syringe from the IV catheter and analysed immediately. At each collection point, 5ml of blood was drawn and discarded before collecting sample blood and catheter lines were maintained through saline flushing. After the catheter insertion, the participant rested for 10 minutes in the testing chair before baseline measures were collected to negate any potential affect the catheterisation could have on subsequent measures. Baseline measures were then recorded in the following order: i. Lateral pinch (see 2.3.1 MVC Assessment); ii. Pain perception (see 2.3.4 Pain Assessment); iii. Blood collection for lymphocyte assessment (see 2.3.5 Lymphocyte Assessment); iv. Blood collection for lactate analysis (see 2.3.6 Blood Lactate Analysis). Following baseline testing, participants undertook either an Exercise Intervention (WLEXP and UTEXP groups) or a Placebo Intervention (WLPLA group). Once the interventions were completed, all participants immediately underwent the following rest and passive testing conditions in the order described: i. Pain Perception: immediately, 10 minutes, 20 minutes and 60 minutes post the interventions; ii. Blood collection for lymphocyte assessment: 20 minutes and 60 minutes post the interventions; iii. Blood collection for lactate analysis: 3 minutes, 10 minutes, 20 minutes and 60 minutes post the interventions. Of note, blood Lactate was first sampled at 3 minutes post-intervention to record peak concentrations (Goodwin, Harris, Hernández, & Gladden, 2007; Vucetic, Mozek, & Rakovac, 2015) . Throughout the duration of the experiment, all subjects remained seated and were instructed against moving the tested limb to avoid any active recovery which could affect the results. IV catheters were removed after the final collection point. All blood samples and raw data were subsequently analysed and statistical analysis applied. 2.3 Procedures 2.3.1 MVC Assessment Assessment occurred using a B & L Engineering pinch gauge (PG-60) with reported reliability and validity (Mathiowetz et al., 1985; Mathiowetz, Vizenor, & Melander, 2000; Mathiowetz, Weber, Volland, & Kashman,1984) . All subjects undertook this assessment to determine their maximum lateral-pinch-strength of the dominant hand only. To eliminate testing bias, one researcher gave instructions and reset the dynamometer and a separate researcher viewed and recorded each test result. Subject encouragement during testing was standardised by using the verbal instructions described previously (Mathiowetz et al., 1984) . Subjects were positioned in the standardised testing position (seated in a chair with arm rests and full back support, the shoulder adducted to neutral and neutrally rotated, elbow flexed at 90°, forearm in the neutral position, and wrist between 0° and 30° dorsiflexion and between 0° and 15° ulnar deviation [Fess & Moran, 1981; Mathiowetz et al., 1985] ). This also controlled for contribution from accessory muscles. Subjects were tested using the protocol previously described (Mathiowetz et al., 1985) . During testing, subjects were instructed to give a maximal effort. Immediately after the first effort was completed, the dynamometer was reset and a second (and final) effort was performed. Values were recorded and later averaged. 2.3.2 Exercise Intervention A previously described low-dose exercise protocol (Szlezak et al., 2015) formed the exercise intervention. Briefly, this involved performing a lateral pinch-manoeuvre in a standardised testing position (Fess & Moran, 1981; Mathiowetz et al., 1985) and utilised a B & L Engineering pinch gauge (PG-60). A lateral-pinch manoeuvre was selected to minimise the potential effects of inter-individual biomechanical variation and accessory muscle exertion on study results (Punsola-Izard et al., 2012) . A total of 4 minutes total-work (isometric thumb resistance-exercise) was performed, divided into four 60-s work-intervals each separated by one, 60-s rest interval. The total time for the exercise intervention was 7 minutes. The first two work intervals were performed at 50% MVC and the remaining two work intervals at 35% MVC (where MVC was determined during the MVC Assessment). Participants continuously monitored the pinch gauge during the work-intervals to ensure they constantly applied the correct load (kg). The standardised command "keep the needle at your weight" was used by a researcher if the applied load changed from that specified (Szlezak et al., 2015) .
2.3.3 Placebo Intervention WLPLA participants undertook the placebo intervention (previously described by Szlezak et al., 2015) which involved 4 work-intervals lasting 60-s separated by 60-s rest-intervals. In contrast to the exercise intervention, WLPLA subjects held the pinch gauge without applying any downward pressure. This was considered a placebo since subjects could not know if they were performing a low-dose exercise intervention or not. Body positioning in the placebo intervention was identical to the exercise intervention. Participants rested during the rest-interval as described in the exercise intervention. A total-time of 7 minutes elapsed during the placebo intervention to maintain consistency with the exercise intervention. 2.3.4 Pain Assessment A pain VAS was employed to validly and reliably assess each participant's perception of exercise-related muscle pain (Douris et al., 2006; Hawker, Mian, Kendzerska, & French, 2011; Sellwood, Brukner, Williams, Nicol, & Hinman, 2007) . An unmarked horizontal 100 mm line with the terminal descriptors ''no pain'' (score of 0) and ''worst pain imaginable" (score of 10) was completed by the participants. Scoring occurred by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the respondent's mark thus providing a range of scores from 0-100 (Jensen, Karoly, & Braver, 1986) . 2.3.5 Lymphocyte Assessment Lymphocyte subpopulation analysis was performed using the BD FACSVerse flow cytometer and the Becton Dickinson Simultest™ IMK Lymphocyte kit for enumeration of B (CD19+) lymphocytes, helper/inducer T (CD3+CD4+) lymphocytes, suppressor/cytotoxic T (CD3+CD8+) lymphocytes and natural killer (CD16+and/or CD56+) lymphocytes (Becton Dickinson, Franklin Lakes, NJ, USA). Lymphocyte cell percentages and absolute counts were calculated and generated automatically on each blood sample using the Simultest IMK-Lymphocyte software once the operator entered the independent data (leukocyte count, leukocyte and lymphocyte percentages; HmX Hematology analyser, Beckman Coulter, Pasadena, CA, USA). 2.3.6 Blood Lactate Analysis Analysis occurred using an automated blood lactate analyser (Lactate Pro, Arkray Inc., Tokyo, JPN) with reported reliability and accuracy (Pyne, Boston, Martin, & Logan, 2000) . The device was calibrated prior to use as specified by the manufacturer. Venous blood was injected into a Lactate Pro test strip direct from the syringe. The analyser was left resting on a stationary table until the blood lactate calculation was finalised and recorded. Values were reported in millimoles per liter (mmol/L).
Statistical Analysis
Values presented are as means ± standard deviation. IBM SPSS Statistics 22 was used for all statistical testing. Fullyfactorial ANOVA with repeated measures was used to determine any interaction among, or main effect of, the independent variables group and time. Least squares difference pairwise comparisons were used to detect the specific site of any significant effect identified. Pearson's correlation coefficients were calculated to determine any relationships among change in blood lactate concentration and change in lymphocyte subpopulation count for each of the participant groups (WLPLA, UTEXP, WLEXP). Statistical significance was accepted at p<0.05.
Results
Subject characteristics are displayed in Table 1 . The results of a one-way ANOVA revealed that no statistical differences were found for age (F=0.114, p=0.892), height (F=0.561, p=0.578) and body mass (F=1.096, p=0.350) variables among the three groups. Moreover, no differences among the three groups were found for any of the measured variables (reported pain, blood lactate, lymphocyte counts) at baseline (p>0.05). 
Pain VAS
A significant interaction for time and group was found for pain (VAS) (F=11.27, p< 0.01). Pairwise Comparisons revealed no significant change in the Placebo group from baseline at any post-intervention time-point (p>0.05). The UTEXP group increased significantly in reported pain immediately post-intervention (2.92/10; p<0.01) and this represented the peak pain response. Pain remained elevated up to 20 minutes post-intervention (p<0.01), before decreasing to levels not significantly different from baseline (p>0.05) at 60 minutes post-intervention. The WLEXP group also reported a highly significant increase in pain immediately post-intervention (4.92/10; p<0.01) and this was the peak pain response. Pain remained elevated across all times points (p<0.01). Maximum pain values were significantly higher in the WLEXP (4.92/10) vs UTEXP (2.92/10) group (p=0.02).
Blood lactate
A significant interaction for time and group was found for blood lactate (mmol/L) (F=26.31, p<0.01). Pairwise Comparisons revealed no significant change in the Placebo group from baseline at any post-intervention time-point (p>0.05). Both experimental groups showed a highly significant increase (p<0.01) in blood lactate concentration at the first post-intervention (3 minutes post) and 10 minutes post-intervention time-points before returning to levels not significantly different from baseline by 20 minutes post-intervention (p>0.05). Peak blood lactate concentrations (UTEXP: 2.2mmol/L; WLEXP: 2.4mmol/L) occurred at 3 minutes post-intervention for both experimental groups and response magnitude was not significantly different between these groups (p>0.05). See Figure 1 .
Figure 1. Blood lactate concentration over time
There was no difference in blood lactate concentration among the three groups at baseline (-7 min; p>0.05). WLPLA: Lactate concentration did not change from baseline across time (p>0.05). UTEXP and WLEXP: Lactate concentration increased (p<0.01) by 3 min post-exercise, remained elevated at 10 min postexercise (p<0.01), and decreased to levels not different from baseline by 20 min post-exercise (p>0.05). Peak concentrations (3 min post: UTEXP: 2.2mmol/L; WLEXP: 2.4mmol/L) were not different between these two groups (p>0.05).
Helper/inducer T lymphocytes (CD4+CD3+)
A significant interaction for time and group was found for CD4+CD3+ lymphocytes (F=4.42, p<0.01). Pairwise Comparisons revealed no significant change in the Placebo group from baseline at any post-intervention time-point (p>0.05). In the UTEXP group, lymphocyte count increased from baseline at 20 minutes post-intervention by 20.78% and this change was highly significant (p<0.01). From 20-60 minutes post-intervention, lymphocyte count decreased back towards baseline count and this was also highly significant (p<0.01). Lymphocyte count at the final time-point (60 minutes post-intervention) was not significantly different from baseline (p>0.05). In the WLEXP group, lymphocyte count did not significantly change between baseline and 20 minutes post-intervention (p>0.05). Lymphocyte count did elevate from 20-60 minutes post-intervention and this change was significant (p=0.01). Lymphocyte count at the final time-point was elevated above baseline by 19.06% and this difference was highly significant (p<0.01). See Figure 2 . 
Suppressor/cytotoxic T lymphocytes (CD8+CD3+)
A significant interaction for time and group was found for CD8+CD3+ lymphocytes (F=3.1, p=0.02) . Pairwise Comparisons revealed no significant change in the Placebo group from baseline at any post-intervention time-point (p>0.05).In the UTEXP group, lymphocyte count increased from baseline at 20 minutes post-intervention by 15.25% and this change was highly significant (p<0.01). From 20-60 minutes post-intervention, lymphocyte count decreased back towards baseline count and this was also significant (p=0.03). Lymphocyte count at the final time-point (60 minutes post-intervention) was not significantly different from baseline (p>0.05).
In the WLEXP group, lymphocyte count did not significantly change between baseline and 20 minutes post-intervention (p>0.05). Lymphocyte count did increase from 20-60 minutes post-intervention however this change did not reach significance (p>0.05). Lymphocyte count at the final time-point had elevated above baseline by 11.46% and this difference was significant (p=0.033). See Figure 3 . 
B lymphocytes (CD19+)
No interaction of time and group was found for CD19+ lymphocytes (F=1.72, p=0.16) however there was a main effect of time (F=6.86, p<0.01). Pairwise comparisons revealed no significant change in the Placebo group from baseline at any post-intervention time-point (p>0.05). In the UTEXP group, lymphocyte count increased from baseline at 20 minutes post-intervention by 18.11% and this change was significant (p=0.013). From 20-60 minutes post-intervention, lymphocyte count decreased back towards baseline count however this change did not reach significance (p>0.05). Lymphocyte count at the final time-point (60 minutes post-intervention) was not significantly different from baseline (p>0.05). In the WLEXP group, lymphocyte count did not significantly change between baseline and 20 minutes postintervention (p>0.05). Lymphocyte count increased from 20-60 minutes post-intervention and this change was significant (p=0.031). Lymphocyte count at the final time-point was elevated above baseline by 28.87% and this difference was highly significant (p<0.01). See 
Natural Killer lymphocytes (CD56+ and or CD16+)
No significant interactions were found for time and groups for CD56+/CD16+ lymphocytes (F=0.23, p=0.92). Additionally, no significant changes in lymphocyte count from baseline occurred across time for any of the three groups (p>0.05). See Figure 5 . Figure 5 . CD56+/CD16+ NK lymphocyte count over time There was no difference in CD56+/CD16 cell count among the three groups at baseline (-7 min; p>0.05). No changes in lymphocyte count from baseline occurred across time for any of the three groups (p>0.05).
Blood lactate -lymphocyte correlation
No correlation was found between change in blood lactate concentration and change in lymphocyte count: CD4+CD3+ (UTEXP r=0.11, p=0.78 ; WLEXP r=0.16, p=0.68), CD8+CD3+ (UTEXP r=0.03, p=0.93; WLEXP r=0.64, p=0 .07), CD19+ (UTEXP r=-0.05, p=0.89 ; WLEXP r= 0.21, p=0.60 ) or CD56+/16+ cell counts (UTEXP r=0.20, p=0.76 ; p=0.99) . The relationship observed between blood lactate concentration and CD8+CD3+ cell count in WLEXP is illustrated in Figure 6 ; nonetheless this relationship was not statistically significant. The relationship observed between changes in blood lactate concentration and changes in CD8+CD3+ cell count in WLEXP (r=0.64) is illustrated. Nonetheless, this relationship was not significant (p>0.05).
Discussion
The present study is the first to demonstrate that a micro-dose of resistance-exercise can significantly elevate circulating B lymphocyte and T lymphocyte counts. Additionally, lymphocyte response profiles were related to the physical aptitude of subjects, and not blood lactate levels. No relationship was found between change in lymphocyte counts (CD4+CD3+ and CD8+CD3+ T cells; CD19+ B cells; CD56+/16+ NK cells) and change in blood lactate concentration for either of the experimental groups. This latter finding disproved our hypothesis that an increase in circulating lymphocyte count is related to an increase in blood lactate concentration. Functionally, these findings indicate that B and T cell trafficking in males is affected by even the smallest of physical exertions. Moreover, cell mobilisation is not regulated by mild elevations in cellular energy demand or anaerobic energy expenditure (Fernandez et al., 2006; Wirtz et al., 2014) however is influenced by physical aptitude of the host.
The present study utilised a micro-dose exercise approach which was brief in duration, low in intensity and anaerobically based (evidenced by increases in blood lactate as hypothesised). This experimental approach was considered critical in order to minimise the potential influence of exercise intensity and duration on the study results (Freidenreich & Volek, 2012; Walsh et al., 2011) so that potential relationships between blood lactate, physical aptitude and lymphocyte homeostasis could be better studied. It was also necessary to investigate the effects of a low-dose resisted exertion on lymphocyte subpopulations.
In the present study, the placebo group did not change for any measured variable across any time-points as expected. For reported pain levels, the significant increase seen for the UTEXP and WLEXP groups indicates that a low intensity, short duration exercise protocol can be highly challenging beyond the physical, even in a well-trained athletic population. Moreover, the pain elevation was shortly lived (< 20 minutes) in the untrained individuals, whereas the response was maintained for at least 60 minutes (final time-point) in the weightlifters. Of note, the weightlifters reported a significantly higher peak pain response compared with the untrained group. As peak blood lactate concentrations between groups were not significantly different, a psychological phenomenon may be responsible for this result. Well trained athletes are known to place higher expectations on oneself than non-athletes (Dunn, Gotwals, & Causgrove Dunn, 2005; Gould, Dieffenbach, & Moffett, 2002) which can be associated with perfectionistic concerns, fear of failure, mental stress and elevated anxiety (Conroy, Willow, & Metzler, 2002; Stoeber et al., 2011) . These alterations in psychological state are known to increase one's perception of pain (Loggia, Schweinhardt, Villemure, & Bushnell, 2008; Rhudy & Meagher, 2000) and likely explain the results of this present study. The magnitude of peak pain reported in this study for the weightlifting subjects (4.92/10) was a novel and unexpected finding considering the micro-dose nature of the exercise protocol. This is evidence that low-intensity, short-duration exercise can be highly demanding depending on the subject population and the targeted muscle groups.
Blood lactate concentrations increased significantly in both experimental groups at 3 minutes post-exercise and had normalised by 20 minutes post-exercise, indicating a similar production and clearance rate between experimental groups. The timing of the peak concentration (3 minutes post-exercise) was consistent with previously reported temporal profiles in larger-dose studies (Goodwin et al., 2007; Vucetic et al., 2015) . Interestingly, lactate profiles between experimental groups were similar and may be explained by the involvement of the thumb muscle in activities of daily living, thus providing a training effect in the untrained group. Importantly, these findings indicated that the IJKSS 4(1):55-66, 2016 63 exercise-intervention challenged each experimental group to a similar level, both physically and anaerobically. The blood lactate profile demonstrated in the present study is a novel and meaningful finding alone. These results show that short duration exercise at a low physical intensity (35% and 50% of MVC) can measurably increase anaerobic energy expenditure in specific skeletal muscle (Fernandez et al., 2006; Wirtz et al., 2014) . For example, a large muscle exercising at 35% MVC may be below lactate threshold for that tissue, however for the small muscle group around the thumb, this same relative intensity was above the lactate threshold. These results show how a low physical intensity of exercise can have meaningful metabolic consequences for specific myocytes. Extrapolating the results of the present study to a practical example, gripping an unloaded barbell would not be considered challenging for a trained athlete, however the coach should now consider the metabolic implications for the smaller gripping muscles, those in the thumb and hand. Additionally, we have shown that a small muscle group exertion can produce high levels of pain, thus researchers and clinicians should view exercise intensity in a broader scope than just the physical.
In relation to lymphocyte subpopulations, no significant change was seen for the CD56+/CD16+ cells. This negative result was inconsistent with the literature (Freidenreich & Volek, 2012) , however as the first measurement was not taken until 20 minutes post-exercise, a response may have occurred and returned to baseline prior to this point. As this study is the first to investigate natural killer cell responses to such a short duration, micro-dose of resistance-exercise, further research should measure natural killer cell counts at more acute post-exercise time-points. Conversely, CD4+CD3+ cells, CD8+CD3+ cells and CD19+ cells all demonstrated a characteristic response pattern to exercise associated with training status. In the UTEXP group, the cell count (circulating) for these cell types had significantly increased at the first post-intervention time-point (20 minutes post-intervention) then significantly decreased back to values not different from baseline by the final time-point. In contrast, a completely different response profile was observed for the WLEXP group. In the WLEXP group, the same cell types showed a delayed increase. No significant increase was seen at the first post-intervention time-point, however cell counts were significantly elevated above baseline at the final time-point.
To reiterate, untrained individuals showed an early increase then a decrease in lymphocyte count, whereas weightlifting trained individuals showed no early increase followed by a delayed increase. Of note, the magnitude in lymphocyte responses were smaller than previously reported data related to high-dose exercise protocols (Freidenreich & Volek, 2012; Walsh et al., 2011) , suggesting that a dose-response relationship does exist for exercise-associated lymphocytosis. However, the lymphocyte responses observed in the present study provide strong evidence that exercise intensity and duration alone do not dictate the response to exercise, as both experimental groups undertook a common exercise protocol yet responded uniquely. Another major finding of the present study is the lack of correlation between blood lactate and lymphocyte subpopulation count as previously reported in females (Miles et al., 2003) . This disagreement between previous observations and those of the present study are likely explainable though differences in study design. The earlier study (Miles et al., 2003) found that high lactate responders (≥11.92 mmol/L) showed significantly greater lymphocyte count elevations than lower lactate responders (≤7.62 mmol/L). In contrast, the present study's low dose exercise protocol induced lower levels of lactate production (≤2.4mmol/L) despite significant lymphocyte count elevation. Additionally, the present study employed all-male subjects whereas Miles and associates (2003) used only females. Also, the results previously reported (Miles et al., 2003) were based on performance of a high-dose multiplejoint (squat) exercise protocol. In consideration of potential inter-individual biomechanical differences (Frank et al., 2013; Solomonow & Krogsgaard, 2001) , standardisation of exercise performance and thus reliability of study results cannot be guaranteed in this latter study. Conversely, the present study utilised a highly controllable exercise intervention with strict standardisation of body positioning, skeletal joint and muscle involvement (Mathiowetz et al., 1985; Punsola-Izard et al., 2012; Towles, Hentz, & Murray, 2008) . Finally, the present study included both well-trained and untrained subjects whereas the previous study recruited previously-untrained subjects only. If lymphocyte redistribution was related to mild elevations in blood lactate concentration, strong correlations should have been calculated for both experimental groups for each of the four lymphocyte subpopulations (which was not the case). Importantly, blood lactate did not differ significantly between weightlifting trained and untrained individuals in the present study. That is, peak concentrations and temporal profiles were not significantly different between experimental groups, however their lymphocyte responses to resistance-exercise where markedly different. A unique lymphocyte response relative to training status was hypothesised, however this was based upon anticipated differences in anaerobic response between groups, which was not seen. This is novel evidence that mild elevations of blood lactate cannot alone explain the selective redistribution of lymphocytes into the circulation (in males). As the present study used a common exercise protocol which exerted all subjects to a similar level of anaerobic glycolytic activity, and considering that blood lactate was cleared at a similar rate, the only significant difference between the groups was the training status variable. From another perspective, the relationship between high blood lactate levels and lymphocyte counts in females (Miles et al., 2003) contrasted with the present study's findings give rise to the notion that lymphocytes may react to lactate above a certain threshold only. Future studies should investigate this suggestion through a stringently controlled exercise protocol which employs multiple anaerobic-doses.
Since blood lactate is associated with exercise-induced catecholamine changes (Pullinen, Nicol, MacDonald, & Komi, 1999) and lymphocytes unlike other leukocytes are uniquely sensitivity to catecholamines (Benschop, Schedlowski, Wienecke, Jacobs, & Schmidt, 1997; Landmann, 1992) , it may be that catecholamines and not blood lactate are responsible for the characteristic lymphocyte profiles observed in the present study. This is plausible since resistancetraining is known to increase the magnitude of catecholamine release during exercise . Future researchers are encouraged to investigate if catecholamines are mechanistically responsible for the relationship between lymphocyte counts and training status post low-dose resistance-exercise. Additionally, lymphocyte functionality should now be examined post low-dose exercise to determine if the associated lymphocytosis carries clinically relevant implications.
Conclusion
The results of our study provide original evidence that significant changes to B and T lymphocyte homeostasis can occur in the absence of high intensity, high volume exercise. Moreover, resistance-exercise induced lymphocytosis cannot be explained by blood lactate when elevations are only mild. This finding does not rule out a potential relationship between blood lactate and lymphocyte trafficking, however suggests another mechanism may be involved at low exercise doses. Until the functional implications of these exercise-induced lymphocyte responses are determined, exercise-professionals are advised to recognise that any dose of resistance-exercise may affect lymphocyte trafficking. Whilst the influence of exercise intensity and duration on leukocyte responses to resistance-exercise have been extensively reported in the literature, our findings demonstrate that B and T lymphocytes specifically, respond to a lowdose of resistance-exercise in a characteristic manner relative to the physical aptitude of the host.
